OSA is a chronic treatable sleep disorder and a frequent comorbidity in patients with type 2
diabetes. Cardinal features of OSA, including intermittent hypoxemia and sleep …

Obstructive sleep apnea (OSA) is an increasingly prevalent condition. A growing body of
literature supports substantial racial disparities in the prevalence, risk factors, presentation …

Rationale: Prior work suggests that Black patients have more severe obstructive sleep
apnea (OSA) upon clinical presentation. However, the extent to which this may reflect …

Obstructive sleep apnoea (OSA) is very common in patients with Type 2 diabetes (T2D),
which is not surprising considering that obesity is a common risk factor for both conditions. In …

IN BRIEF Obstructive sleep apnea (OSA) alters glucose metabolism, promotes insulin
resistance, and is associated with development of type 2 diabetes. Obesity is a key …

OSA is associated with insulin resistance and β-cell dysfunction independent of obesity.
OSA is associated with HbA1c and vascular complications in patients with T2D. CPAP might …

Purpose Obstructive sleep apnea (OSA) is highly associated with type 2 diabetes mellitus
(DM), and treatment of OSA may have a positive impact on cardiometabolic profile. This …

Obstructive sleep apnoea (OSA) is a common disorder that is associated with serious
comorbidities with a negative impact on quality of life, life expectancy and health costs. As …

Background Although there is a strong association between obesity and obstructive sleep
apnoea (OSA), the effects of OSA and CPAP therapy on weight loss are less well known …

Obstructive sleep apnoea (OSA) is common and is associated with many vascular risk
factors, such as hypertension, insulin resistance, albuminuria, dyslipidaemia, increased …